Fundraising Fox
Coridea
1 known investors
Find your way into Coridea
Each arrow is one introduction. Sign up to fill in the first one.
273 people can intro you to Zoar
Ask Mark Christopherson to introduce you to Zoar Engelman
You →Mark · together at Lunair Medical →Zoar
58 people can intro you to Adam
Ask Jamie Chen to introduce you to Adam Rosenwach
You →Jamie · together at Axon Therapies Inc. →Adam
46 people can intro you to Mark
Ask Sam Okafor to introduce you to Mark Gelfand
You →Sam · together at Coridea →Mark
- Howard R. Levin37 people can intro you
Sign up to find every way you can get introduced to Coridea
- Your email: who you already know at Coridea, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Coridea team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.
Founders & leadership
MG
Mark GelfandManaging Partner and Chief Technical OfficerMark Gelfand has over 25 years of experience in medical device development across academic, startup, and corporate settings, with expertise in integrative physiology, systems engineering, and intellectual property. He co-founded multiple healthcare companies including Axon Therapies, Soffio Medical, Cibiem, CHF Solutions, Ardian, and Respicardia, served as CTO at several medical device firms including CardioLogic Systems and Nellcor Puritan Bennett, and holds a master's degree in electrical engineering from St. Petersburg Institute of Technology and graduate-level physiology training from Johns Hopkins School of Medicine.
HR
Howard R. LevinManaging Partner, President, and Chief Medical OfficerHoward Levin is a cardiologist trained in heart failure and transplantation who now serves as managing partner, president, and chief medical officer of Coridea, a healthcare investment firm developing patient-centric medical technology ventures.
ZE
Zoar EngelmanPartner and Chief Scientific OfficerZoar Engelman is Partner and Chief Scientific Officer at Coridea, which invests in and develops healthcare companies focused on patient-centric medical technology and healthcare ventures.
AR
Adam RosenwachPartner and Chief Business OfficerPartner and Chief Business Officer at Coridea, an investment firm in healthcare technology. Rosenwach previously founded Star51 Capital to connect healthcare innovators with corporate and venture partners, and spent over a decade in medtech operations managing early-stage company development and fundraising; he holds degrees from Berklee College of Music and Wharton.
Investors · 1
Founder mafia
4 people who came through Coridea went on to found or lead other companies.
Zoar EngelmanPartner and Chief Scientific OfficerFounded Deerfield Catalyst +2Mark GelfandManaging Partner and Chief Technical OfficerFounded Deerfield Catalyst +1Ming Jack PoEntrepreneur in ResidenceFounded Ansible HealthHoward R. LevinManaging Partner, President, and Chief Medical OfficerFounded Deerfield Catalyst
Non-dilutive funding · 13 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $907.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $278.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $246.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $997.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Coridea do?
- Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.
- Who founded Coridea?
- Coridea was founded by Mark Gelfand, Howard R. Levin.
- Who are Coridea's investors?
- Coridea's investors include Broadview Ventures.